Skip to main content
Advertisement
  • Loading metrics

Neotropical bats as sentinels for emerging zoonoses in Central America: A case study identifying Trypanosoma cruzi in bats from Belize using metagenomic next-generation sequencing

  • Elissa G. Torgerson,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, Indiana, United States of America

  • Michele Adams,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – review & editing

    Affiliation Department of Biological Sciences, College of Science, University of Notre Dame, Notre Dame, Indiana, United States of America

  • Lauren R. Lock,

    Roles Investigation, Writing – review & editing

    Affiliation School of Biological Sciences, College of Arts and Sciences, University of Oklahoma, Norman, Oklahoma, United States of America

  • Molly C. Simonis,

    Roles Investigation, Writing – review & editing

    Affiliations School of Biological Sciences, College of Arts and Sciences, University of Oklahoma, Norman, Oklahoma, United States of America, College of Forestry, Wildlife and Environment, and College of Veterinary Medicine Department of Pathobiology, Auburn University, Auburn, Alabama, United States of America

  • Kristin E. Dyer,

    Roles Investigation, Writing – review & editing

    Affiliation School of Biological Sciences, College of Arts and Sciences, University of Oklahoma, Norman, Oklahoma, United States of America

  • Amanda Vicente-Santos,

    Roles Investigation, Writing – review & editing

    Affiliation School of Biological Sciences, College of Arts and Sciences, University of Oklahoma, Norman, Oklahoma, United States of America

  • M. Brock Fenton,

    Roles Investigation, Writing – review & editing

    Affiliation Department of Biology, Western University, London, Ontario, Canada

  • Nancy B. Simmons,

    Roles Investigation, Writing – review & editing

    Affiliation Department of Mammalogy, American Museum of Natural History, New York, New York, United States of America

  • Daniel J. Becker,

    Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliation School of Biological Sciences, College of Arts and Sciences, University of Oklahoma, Norman, Oklahoma, United States of America

  • Nicole L. Achee

    Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    nachee@nd.edu

    Affiliation Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America

Abstract

Emerging zoonoses remain a global public health concern. Surveillance of infectious and vector-borne diseases is vital for predicting and mitigating detrimental effects of zoonotic spillover events. Beyond assessing what microorganisms are circulating in specific environments, it is important to understand how potential reservoir hosts, especially animals such as bats, participate in pathogen transmission. Bats can host and potentially spread infections caused by bacteria, viruses, fungi, and protozoa. However, bats can also act as sentinels that test positive for pathogenic microorganisms without necessarily contributing to the pathogen replication cycle. Metagenomic next-generation sequencing (mNGS) provides an efficient means to broadly screen for pathogens, although microorganism selectivity can sometimes be lower than targeted approaches. Pairing mNGS results with higher-sensitivity tests such as quantitative PCR (qPCR) can validate results and together these tools provide a relatively fast and reliable method for conducting surveillance. To test this approach, we conducted an exploratory study surveying the types of microorganisms circulating in Belize by collecting 263 blood samples from 20 different bat species captured in the Orange Walk District in 2019, 2022, and 2023. We used mNGS to initially characterize the microbial communities and qPCR to confirm presence and intensity of human pathogens of interest. We detected 1,430 different microorganisms with some relevance to human or animal health, including the protozoan Trypanosoma cruzi, which was detected in the phyllostomid bats Desmodus rotundus and Artibeus jamaicensis. qPCR confirmed the presence and intensity of Trypanosoma cruzi in mNGS-positive bat samples. We documented the types of pathogenic microorganisms circulating throughout the bat community in northern Belize to demonstrate the capacity for bats to serve as sentinels.

Author summary

Tracking the spread of new and emerging zoonotic diseases is a major component of global health research. Pathogen surveillance is a vital part of predicting and reducing the consequences of disease outbreaks. Bats are a diverse group of mammals that can host and potentially transmit many pathogens that pose potential risks to human and environmental health. Our exploratory study surveyed blood samples (n = 263) from 20 bat species collected from the Orange Walk District of Belize in 2019, 2022, and 2023. Metagenomic next-generation sequencing identified 1,430 different microorganisms that are considered potentially relevant to human or animal health. Among the microorganisms detected was Trypanosoma cruzi (T. cruzi), the protozoan causative agent of Chagas disease. T. cruzi was of particular interest due to its presence throughout the Americas and relevance to public health. We surveyed the types of microorganisms circulating throughout bat populations in northern Belize to demonstrate the ability of bats to act as sentinels.

Introduction

Risks associated with emerging zoonoses are increasing as populations of humans and livestock grow and the world continues to become more interconnected and interdependent. Instability of various kinds (political, economic, environmental) encourages movements of people, while limited medical resources jeopardize community health, and climate change influences vector distributions [1]. Increasing atmospheric temperatures are limiting some resources and decreasing habitable land [2]. For these reasons, the expansion of disease surveillance and neglected disease research are a necessity, as risk of infection is no longer isolated to contained regions. Human mobility inevitably increases pathogen mobility [3]. Infection rates are likely to rise as proximity between human populations declines and vectors acclimate to new environments. In addition, increases in unusual and severe weather conditions can facilitate the spread of pathogens through contaminated resources (i.e., water, food, air, and livestock) [4,5]. Changes in land use have also facilitated greater overlap of people with wildlife and concomitantly led to increases in zoonotic spillover risk [68]. Humans are not the only ones being affected by growing pressures resulting from climate change and habitat conversion, as many animal and non-animal organisms, such as bats, are having to adapt to survive [9]. Bats are important animals to consider when conducting surveillance because they can host a large number of pathogens, are known to participate in cross-species pathogen transmission, and they are reservoirs for important zoonotic pathogens like rabies lyssavirus, Hendra and Nipah henipaviruses, and Marburg filovirus [1012].

Bats are a diverse and wide-spread group of mammals that inhabit a variety of ecosystems and exploit both urban and non-urban settings [13]. Healthy bat populations are essential for maintaining balanced ecosystems as they provide services like seed dispersal, plant pollination, and agricultural pest predation [7,14,15]. By participating in activities that support ecosystem biodiversity, bats contribute positively to the socio-economic status of the regions they inhabit [16]. While bats provide many ecological benefits, close proximity to humans increases the likelihood of a zoonotic spillover event [7,17]. It is becoming increasingly common for bats to reside in agricultural and urban environments and alter their diet to accommodate their change in habitat [18,19]. Climate change, the destruction of natural habitat, and rising competition for natural resources have played notable roles in altering bat behavior [20].

The increase in bats residing in urban and agricultural environments can be detrimental to bat health and, in turn, potentially human and domestic animal health [7,2123]. For example, as the diets of bats shift to accommodate new food sources, their microbiota composition also changes, often with gut biodiversity declining in anthropogenic environments [2426]. For some bat species, moving into urban and agricultural environments is also associated with a decline in immunity, potentially increasing susceptibility to infections and extending infectious periods [27,28]. Foraging within anthropogenic environments has especially affected the immune profiles of common vampire bats (Desmodus rotundus) because of their exclusively blood diet. While the effects of this behavioral shift are not entirely understood, it has been observed that when vampire bats switch to primarily consuming the blood of livestock, their immune systems can switch to favoring investment in innate immunity, as opposed to adaptive immunity [29]. Robust adaptive immune responses are crucial for host defense against viral pathogens, which means an increase in the reliance of bats on domestic animal prey could compromise their ability to fight-off infection [19,29,30]. Greater reliance on more abundant and stable anthropogenic food sources at the cost of lowering overall immunity has been observed across many bat species. For example, Australian flying foxes (Pteropus spp.) rely on poorer quality fruit and nectar resources in urban and agricultural habitats in response to food shortage events, leading to higher stress, decreased immunity, and amplified pulses of Hendra virus shedding and spillover to horses [3133]. In addition to modifying bat immunity, foraging in urban and agricultural environments also increases overlap among bats, domestic animals, and humans, increasing opportunities for pathogen spillover.

While bats may not necessarily have a greater fraction of zoonotic viruses than other mammal or avian taxa [34], bats can serve as competent hosts for some virulent human-infecting pathogens, possess high antibody gene diversity, and have remarkable immune tolerance compared to other mammals [3537]. The combination of these immunological factors and propensity to forage and even roost in urban and agricultural environments fosters opportune conditions for zoonotic spillover [38,39]. As such, it is vital that locations and situations that place humans at higher risk of zoonotic spillover (i.e., tropical climate, poor sanitation, close human to animal proximity, natural disasters) are recognized, people are informed of potential threats, and steps are taken to minimize risk [7]. When planning to prevent potential zoonotic spillover, vital information includes understanding the diversity of pathogens present in both wildlife hosts and the environment. Here, we address this concern by conducting an exploratory inquiry into using bats as sentinels by reporting results of a comprehensive survey of potentially pathogenic microorganisms detected in bat blood samples collected in Belize.

Current surveillance methods used both in and outside of Belize primarily employ targeted approaches such as PCR [4042], with downstream applications including risk maps and sequencing samples collected from vectors found within the vicinity of confirmed human cases of specific diseases [43,44]. While such approaches are helpful for reliably detecting specific microorganisms of interest, they lack the ability to provide a comprehensive overview of the microorganisms that a host could potentially transmit. Metagenomic next-generation sequencing (mNGS) can detect low concentrations of total nucleic acids (TNA) from a wide variety of microorganisms [4547], yet it is an underutilized tool for surveillance research.

Here we used mNGS to profile TNA of blood samples from a diverse range of bat species in Belize, including some that have close interactions with humans and domestic animals (e.g., Desmodus rotundus). We referenced the National Center for Biotechnology Information [48] and the Chan Zuckerberg Identification Database [49] to identify human and animal pathogens, which we confirmed using qPCR. We were especially interested in attempting to detect Trypanosoma cruzi, the causative agent of Chagas disease, given its relevance to human health in Belize and throughout the Americas [44,50,51]. While T. cruzi is transmitted to humans by triatomine vectors, bats have been implicated in the Chagas disease cycle throughout the Americas [5255]. Currently, the primary non-invasive surveillance method for detecting Chagas disease in Belize is through community collections of Triatoma dimidiata sensu lato (Reduviidae: Triatominae), which is the predominant Chagas disease vector in the country [40,44]. Community collections rely on residents of specific study areas capturing insects that resemble Triatoma dimidiata sensu lato and storing them until the Belize Ministry of Health can collect, verify the identity, and test each insect for T. cruzi. Recently, we used targeted PCR to show that T. cruzi circulates in Desmodus rotundus in Belize, such that other sympatric bat species may also play a role in local transmission cycles [56,57]. With this in mind, targeting bats as sentinels could offer an efficient, secondary, non-invasive method for Chagas disease surveillance in Belize.

Methods

Ethics statement

Field procedures were performed by trained personnel according to guidelines for the safe and humane handling of bats published by of the American Society of Mammalogists [58] and were approved by the Institutional Animal Care and Use Committees of the American Museum of Natural History (AMNHIACUC-20190129 and -20210614) and the University of Oklahoma (2022–0197).

Bat sampling

During two weeks in each of April–May 2019, 2022, and 2023, we sampled bats within the Lamanai Archeological Reserve, Orange Walk District, Belize, as part of broader studies on bat immunology and infectious disease [21,59,60]. As described previously, we used mist nets and harp traps to capture bats along flight paths and occasionally at the exits of roosts, typically from 19:00 hours until 24:00 hours. Bats were kept in clean individual cloth bags prior to processing and were identified and sexed based on morphology [61]. We collected small (<1% body mass) volumes of blood by lancing the propatagial vein with sterile needles (26–30G) followed by collection with heparinized capillary tubes. Bats were released following processing. For this study, blood was stored on Whatman FTA cards at room temperature until –20°C storage at the University of Oklahoma. Fieldwork and sampling were authorized by the Belize Forest Department under permits FD/WL/1/19(06), FD/WL/1/19(09), FD/WL/1/21(12), and FD/WL/1/22(54). For this study, we analyzed 263 blood samples collected from across 20 different bat species in the Belize study region (Fig 1).

thumbnail
Fig 1. Species of bats sampled.

Total number of individual bat species collected in Lamanai, Belize from which blood samples were tested using metagenomic next-generation sequencing (mNGS). Refer to S1 table for a list of the numbers of each bat species collected in Belize.

https://doi.org/10.1371/journal.pntd.0013851.g001

We processed and tested all samples according to procedures written by the Remote Emerging Disease Intelligence-NETwork [6264]. Some changes were made to operating procedures between the years 2023 and 2024, which are noted below.

TNA extraction

We extracted and sequenced samples over the course of a two-year period. Bat samples collected in 2019 were tested in 2023, while samples collected in 2022 and 2023 were tested in 2024. For all samples, we punched three 3-mm sections containing samples of dried blood spots from FTA cards into a 1.5 mL microcontainer containing zirconium oxide beads. Nucleic acid extraction began by adding 20 µL of proteinase K from an Indical IndiMag Pathogen Kit (Indical BioScience, Florida, USA) to each individual sample, as well as a tube containing no sample which served as a negative control. For the samples processed in 2023, 500 µL of Qiagen QIAcard FTA Wash buffer (Qiagen, Hilden, Germany) was added to each sample. For samples processed in 2024, 200 µL of Qiagen ATL-DX buffer, and 200 µL of Qiagen QIAcard FTA Wash buffer was added to each of the samples. Samples were vortexed and incubated for 1 hour at 56oC and 1400 rpm. A ThermoFisher KingFisher Flex System (ThermoFisher Scientific, Massachusetts, USA) and an IndiMag Pathogen kit were used for extraction. DNA and RNA concentration measurements were recorded and 75 µL of TNA from each sample was stored for future use.

Complementary DNA synthesis

Only samples tested in 2024 were used for complementary DNA (cDNA) synthesis. cDNA synthesis was performed using 8 µL of extracted TNA. A tube containing 8 µL of nuclease-free water was used as a negative control. Invitrogen ezDNase Enzyme (ThermoFisher Scientific, Massachusetts, USA) was added to the total nucleic acid, digesting the DNA and allowing the RNA to remain intact. Next, NEBNext Ultra II RNA First Strand Synthesis Module (New England Biolabs (NEB), Massachusetts, USA) and NEBNext Ultra II Non-Directional RNA Second Strand Synthesis Module enzymes were added to create double-stranded cDNA which was then purified. Ten (10) µL of cDNA was combined with 10 µL of genomic DNA (gDNA) from its corresponding sample, producing a total volume of 20 µL for library preparation.

gDNA and TNA sequencing

For sequencing library preparation, we used 20 µL of gDNA for the samples tested in 2023 and 20 µL of TNA for the samples tested in 2024. Tubes containing 20 µL of nuclease-free water were included as negative controls. DNA concentrations for each individual sample were recorded using a Qubit 4 Fluorometer (ThermoFisher Scientific, Massachusetts, USA), with the lowest concentration samples having undetectable amounts of DNA, while the highest concentration sample had 0.987 ng/µL. RNA concentrations were also recorded for TNA samples and ranged from undetectable to 13.3 ng/µL. There was no minimum DNA or RNA concentration required for sequencing. Fragmented DNA was subjected to end-prep repair using NEBNext Ultra II End Repair/dA-Tailing Module and NEBNext FFPE DNA Repair Mix. Barcodes were added from a Native Barcoding Kit 96 V14 (Oxford Nanopore Technologies (ONT), Oxford, UK). After samples were purified, a library pool for multiplex sequencing was created by combining 12 µL from each of the barcoded samples. Adapter ligation was performed using Native Adapter from the ONT Native Barcoding Kit combined with ligase and ligation reaction buffer from the NEB Quick Ligation Kit. After washing the library sample using ONT Short Fragment Buffer, 13 µL of eluate was obtained using ONT Elution Buffer. Library concentration was then measured using 1 µL of sample and a Qubit 4 Fluorometer (ThermoFisher Scientific, Massachusetts, USA).

A mNGS approach was used to test samples. Samples were sequenced on either a ONT GridION or PromethION P2 Solo instrument. Both the GridION and the PromethION used MinKNOW operating software v21.11.7 for high accuracy basecalling. Sequencing ran for 48 hours, and the minimum read length was 200 bp. Sequencing data were then aggregated and pushed through the REDI-NET Custom Pipeline, which uses a nucleotide-based read classifier to identify pathogens of interest to the genus or species level. At the time of sample sequencing, the REDI-NET Pipeline used EDGE v2.4.1 for barcode trimming, removing reads with q-scores less than 9, and filtering out host DNA [65]. DIAMOND v2.0.14 was used to align reads to the National Center for Biotechnology Information (NCBI) Reference Sequence (RefSeq) database, and MEGAN6 v6.23.2 was used to visualize data and record taxon read counts [66]. Identifications of all microorganisms were confirmed using NCBI BLAST+ 2.13.0 (see S4 table) [67]. For samples of interest that tested positive using mNGS, such as T. cruzi (see Results), pathogen confirmation was completed using qPCR.

qPCR confirmation

We used qPCR to confirm any mNGS-positive samples for T. cruzi, given the medical importance of this human-infecting pathogen [44,50]. The PCR mix for T. cruzi contained 1x TaqMan™ Fast Advanced Master Mix (ThermoFisher Scientific, Massachusetts, USA), 0.75 μM of primer 1 (5’ AGT CGG CTG ATC GTT TTC GA 3’), primer 2 (5’ AAT TCC TCC AAG CAG CGG ATA 3’), TaqMan™ probe (5’ 6-FAM-CAC ACA CTG GAC ACC AA-QSY 3’) [68], 4 μL template DNA, and nuclease-free water, totaling a volume of 20 μL. Both positive and negative controls were run with samples. Negative controls were nuclease-free water, and template DNA samples that when sequenced tested positive for a Trypanosoma species, but negative for T. cruzi. The positive control used was gDNA extracted from the T. cruzi parasite. To complete T. cruzi extraction, a total of 80 µL of ATL-DX Lysis Buffer was transferred into a pre-labeled 1.5 mL bead tube containing 2 scoops of 0.1 mm zirconium oxide beads. A total of 320 µL of the T. cruzi parasite was added to the tube and vortexed on its side for 1 minute. The tube was put on ice and allowed to settle for 1 minute before being vortexed on its side again for another minute. The sample was centrifuged at 120 x g for 5 minutes and 350 µL of supernatant was transferred to a new microcentrifuge tube, avoiding bead carryover. Extractions were completed for 1:100 and 1:1,000 T. cruzi sample dilutions. DNA and RNA concentrations of positive controls were recorded and gel electrophoresis confirmed positive control efficacy. Samples were tested on a ThermoFisher QuantStudio™ 7 Flex programmed to run at 95°C for 15 minutes, then cycle 45 times at 95°C for 10 seconds, and 54°C for 1 minute. Fluorescence was measured at the end of each cycle at 54°C. Fragments were approximately 166 base pairs [69].

Results

Our mNGS pipeline detected a total of 1,430 different microorganisms representing bacteria, protozoa, and fungi from 10,878 sequencing reads across the 20 types of sampled Belize bat species. Of the 1,430 taxa, 124 (8.67%) were identified as having some relevance to public health because of their current or potential ability to cause human infection [48,49]. Fig 2 depicts the percentage of the microorganisms identified as having the potential to affect human health.

thumbnail
Fig 2. Pathogens detected in bat blood samples.

The percentage of each pathogen group identified in bat blood samples (n=263) as posing potential risk to human health. Blue symbolizes bacteria, orange represents protozoa, and purple signifies fungi. Refer to S2 table for a full microorganism list including pathogens detected in <0.5% of samples. Refer to S1 Fig to view microorganisms present in at least 10% of blood samples.

https://doi.org/10.1371/journal.pntd.0013851.g002

The most abundant microorganism with the broadest distribution across bat species was Ralstonia mannitolilytica, appearing in 97.7% (257/263) of samples in our study. T. cruzi was detected in six bat samples across multiple species including Desmodus rotundus, Neoeptesicus furinalis, Artibeus jamaicensis, and Sturnira parvidens, representing an overall prevalence of 2.28% (95% confidence interval: 1.05–4.89%). The Trypanosoma genus was also detected in an additional five bat samples from species Desmodus rotundus, Uroderma convexum, Pteronotus fulvus, Pteronotus mesoamericanus, and Carollia sowelli. Of the six samples that tested positive for T. cruzi using mNGS, only four tested positive using qPCR (1.52%, 95% confidence interval: 0.59–3.84%; Fig 3).

thumbnail
Fig 3. Trypanosoma cruzi qPCR amplification plot.

(A) 1:100 C + , positive control, 2 μL 1:100 dilution Trypanosoma cruzi gDNA; (B) 1:1,000 C + , positive control, 2 μL 1:1,000 dilution Trypanosoma cruzi gDNA; (C) OBZB-00154, 2.0 μL DNA from sample positive for Trypanosoma cruzi via mNGS; (D) OBZB-00254, 2.0 μL DNA from sample positive for Trypanosoma cruzi via mNGS; (E) OBZB-00161, 2.0 μL DNA from sample positive for Trypanosoma cruzi via mNGS; (F) OBZB-00095, 2.0 μL DNA from sample positive for Trypanosoma cruzi via mNGS. Refer to S3 table for a full list of qPCR amplification plot results.

https://doi.org/10.1371/journal.pntd.0013851.g003

Discussion

Emerging zoonoses are global public health concerns exacerbated by growing pressures from climate and land use change. Surveillance of infectious and vector-borne diseases is essential for mitigating the detrimental effects of zoonotic spillover. It is important to understand not only which microorganisms are circulating the environment, but also which hosts are (or could become) reservoirs for these infections. Bats can spread an array of infections caused by bacteria, viruses, fungi, and protozoa, although it is not fully understood the extent to which bats participate in zoonotic spillover [24,34]. The primary goal of this study was to determine what microorganisms are circulating throughout bat communities residing in the Lamanai Archeological Reserve located in northern Belize. mNGS was the preferred method for conducting this exploratory surveillance project, given that it can broadly screen for an array of microorganisms without the use of specific primers. In total, 1,430 different microorganisms considered potentially relevant to the health of humans and/or animals were detected using this shotgun approach. One pathogen of particular interest that we detected was T. cruzi, which was confirmed in four out of six mNGS-positive samples using qPCR. Surveying bats via mNGS provides broad information on both target and non-target pathogens, providing a cost-effective method of monitoring infectious disease risks in a diverse and abundant mammal group. In addition to serving as sentinels for possible zoonotic risks, sampling bats for T. cruzi could provide a valuable alternative to direct sampling of triatomines, given uncertainty in whether bats could directly transmit this pathogen to humans. Monitoring work will need to weigh the costs and benefits of bat versus triatomine sampling for this specific pathogen [40].

The presence of microorganisms relevant to humans, even when direct transmission is unlikely, raises questions about what types of bat and pathogen dynamics are at play. While T. cruzi has several routes of transmission, the primary one occurs when the feces or urine of triatomine bugs come into contact with host mucous membranes or a region of the host body where the skin barrier has been broken by a bug bite [70]. Infection can also occur through blood-based and vertical transmission [71,72]. While there is molecular evidence that supports T. cruzi having evolved from a bat trypanosome precursor, sufficient evidence does not exist to demarcate bats as reservoirs for T. cruzi [73]. However, some findings do suggest that infected bats could inadvertently transmit T. cruzi to other animals, even if bats are the dominant source of pathogen maintenance in the host community. For example, there have been instances of T. cruzi spreading via congenital transmission [74] and by oral transmission [75]. Related to this latter transmission route, T. cruzi has been detected in the saliva of vampire bats and other sympatric frugivorous bat species [53] which could be the result of food resources contaminated by T. cruzi parasites [54]. However, the detection of microorganisms in only blood samples here raises questions about how and why these pathogens are circulating within bat communities. Bats have a distinct tolerance of some pathogens compared to other mammals [36,76], although current understandings of how bat immune systems function and respond to infection has been skewed towards host-viral interactions. Limited work has addressed the bat immune response to protozoan infections, although recent work on vampire bats has suggested bats have at least some level of immune tolerance against T. cruzi [56].

Previous reports that have detected T. cruzi in bat communities across the Americas suggest diet and behavior could contribute to the likelihood of bats testing positive for this infection. One study from Colombia detected higher prevalence of T. cruzi discrete typing units in cave-dwelling bats compared to other classes of discrete typing units [77], while a study from Brazil found that fruit bats were more likely to test positive for T. cruzi compared to bats from other dietary guilds [78]. In Ecuador, nectivorous/omnivorous Glossophaga soricina residing in a peri-urban environment tested positive for T. cruzi [79], while a study from Mexico detected T. cruzi in two frugivorous bat species: Artibeus jamaicensis and Sturnira parvidens [80]. Among these studies, T. cruzi prevalence was relatively low, ranging between 1% and 17% of individuals. Comparatively, our results fit within this range, as we confirmed the presence of T. cruzi in at least 1.52% of bats sampled at our site (using qPCR). Most of the qPCR positives were from vampire bats (Desmodus rotundus), with one positive originating from the frugivore Artibeus jamaicensis (mNGS detections not confirmed by qPCR were also found in the insectivorous Neoeptesicus furinalis and the frugivorous Sturnira parvidens). While the factors that increase or decrease T. cruzi infection risk in bats remain poorly understood, detection of this pathogen in blood- and fruit-eating bat species provide further support for the role that foraging ecology might participate in bat–trypanosome dynamics. However, more research is required to determine specifically what factors contribute to the perpetuation of T. cruzi in bat communities and the environment.

When considering how and why bat blood samples are testing positive for T. cruzi, it is important to examine the issue from both ecological and methodological standpoints. mNGS is a relatively new technology, and it is possible that errors could have occurred with sequencing [81]. mNGS is good at detecting multiple pathogens at once without the need for primers [47], and it is also able to identify pathogens that are typically considered more difficult to detect by conventional pathogen identification methods [45,82]. However, there is no universal bioinformatic pipeline used to process mNGS sequencing data, which can cause uncertainty when interpreting results as they can vary across laboratories or between sequencing runs [83]. The increased sensitivity and broad, unbiased approach of mNGS can also increase the chance of false positives [84,85]. Sequencing misalignments and environmental contamination can also make differentiating between pathogenic and non-pathogenic microorganisms (especially those that are genetically related) difficult when interpreting results. In addition, mNGS is typically slower than target approaches like PCR when identifying antimicrobial-resistant genes and mNGS is generally more expensive compared to other pathogen detection methods [86]. However, when used in conjunction with target approaches like PCR, our study has found mNGS to be a reliable and efficient method for pathogen identification.

After confirming the presence of T. cruzi in our bat samples, we returned to the question of how and why this pathogen is circulating in bat communities. Integrating information about host-pathogen dynamics could be crucial for understanding how pathogenic microorganisms can be detected within the blood of hosts in cases where the host does not become ill and pathogen replication does not take place. One idea is that hosts are acting as sentinels and not necessarily reservoirs. Sentinels are generally defined as species that respond rapidly and in a quantifiable manner to changes in their environment [87], while reservoirs are species that not only harbor disease-causing organisms but also serve as sources of transmission and facilitate pathogen maintenance [88]. We are defining bats as sentinels as opposed to reservoirs because of insufficient evidence that these animals can transmit T. cruzi; however, T. cruzi can still be detected in their blood, indicating if levels circulating in the environment have changed. Overall, this study has demonstrated the capacity for bats to be sentinels for Chagas disease, while also displaying how shotgun approaches like mNGS can be utilized in combination with targeted approaches like qPCR to confirm the presence of certain pathogens of interest. Distinguishing whether host species are functioning as sentinels or reservoirs is vital when conducting surveillance research because it provides information that can be used to evaluate public health risk and design effective mitigation strategies.

Supporting information

S1 Fig. Microorganisms detected in at least 10% of bat blood samples.

Microorganisms present in at least 10% of all bat blood samples (n = 263) as identified using mNGS.

https://doi.org/10.1371/journal.pntd.0013851.s001

(TIF)

S1 Table. Bat species collected in Belize, Central America from which samples were tested using metagenomic next-generation sequencing.

https://doi.org/10.1371/journal.pntd.0013851.s002

(DOC)

S2 Table. Microorganisms detected in blood samples using metagenomic next-generation sequencing.

https://doi.org/10.1371/journal.pntd.0013851.s003

(XLSX)

S3 Table. Quantitative PCR amplification plot results for controls and samples that tested positive for Trypanosoma cruzi using metagenomic next-generation sequencing.

C- water, no template control; 1:100 C + , positive control; 1:1,000 C + , positive control; OBZB-00171, negative control; OBZB-00095; OBZB-00121; OBZB-00154; OBZB-00161; OBZB-00165; OBZB-00254.

https://doi.org/10.1371/journal.pntd.0013851.s004

(DOC)

S4 Table. NCBI databases BLAST+ used to confirm microorganism identities.

Databases totaling 726 GB retrieved from https://github.com/ncbi/blast_plus_docs#blast-databases.

https://doi.org/10.1371/journal.pntd.0013851.s005

(DOC)

Acknowledgments

We thank Mark Howells, Karen Gonzalez, Neil Duncan, and staff of the Lamanai Field Research Center for assistance with field logistics and permits. We also thank the many colleagues who helped capture bats during 2019, 2022, and 2023 bat research trips in Belize. We also thank Bret Demory for assistance with sample preparation. Finally, we would like to thank the REDI-NET Consortium for developing the technology and standard operating procedures used for sample processing, testing, and data analysis [https://redi-net.nd.edu].

References

  1. 1. Marcus H, Hanna L, Tait P, Stone S, Wannous C, A product of the World Federation of Public Health Associations Environmental Health Working Group. Climate change and the public health imperative for supporting migration as adaptation. J Migr Health. 2023;7:100174. pmid:36968560
  2. 2. Thornton F, Serraglio DA, Thornton A. Trapped or staying put: Governing immobility in the context of climate change. Front Clim. 2023;5:1092264.
  3. 3. Tsui JL-H, Pena RE, Moir M, Inward RPD, Wilkinson E, San JE, et al. Impacts of climate change-related human migration on infectious diseases. Nat Clim Chang. 2024;14(8):793–802. pmid:41624152
  4. 4. Semenza JC, Rocklöv J, Ebi KL. Climate Change and Cascading Risks from Infectious Disease. Infect Dis Ther. 2022;11(4):1371–90. pmid:35585385
  5. 5. Wang Z, Pei S, Cui H, Zhang J, Jia Z. Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases. J Med Virol. 2024;96(6):e29737. pmid:38874191
  6. 6. Plowright RK, Reaser JK, Locke H, Woodley SJ, Patz JA, Becker DJ, et al. Land use-induced spillover: a call to action to safeguard environmental, animal, and human health. Lancet Planet Health. 2021;5(4):e237–45. pmid:33684341
  7. 7. Plowright RK, Ahmed AN, Coulson T, Crowther TW, Ejotre I, Faust CL, et al. Ecological countermeasures to prevent pathogen spillover and subsequent pandemics. Nat Commun. 2024;15(1):2577. pmid:38531842
  8. 8. Rulli MC, D’Odorico P, Galli N, John RS, Muylaert RL, Santini M. Land Use Change and Infectious Disease Emergence. Rev Geophys. 2025;63:e2022RG000785.
  9. 9. Edelson PJ, Harold R, Ackelsberg J, Duchin JS, Lawrence SJ, Manabe YC, et al. Climate Change and the Epidemiology of Infectious Diseases in the United States. Clin Infect Dis. 2023;76(5):950–6. pmid:36048507
  10. 10. Weber N, Nagy M, Markotter W, Schaer J, Puechmaille SJ, Sutton J, et al. Robust evidence for bats as reservoir hosts is lacking in most African virus studies: a review and call to optimize sampling and conserve bats. Biol Lett. 2023;19(11):20230358. pmid:37964576
  11. 11. Letko M, Seifert SN, Olival KJ, Plowright RK, Munster VJ. Bat-borne virus diversity, spillover and emergence. Nat Rev Microbiol. 2020;18(8):461–71. pmid:32528128
  12. 12. Ruhs EC, Chia WN, Foo R, Peel AJ, Li Y, Larman HB, et al. Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses. Front Public Health. 2023;11:1212018. pmid:37808979
  13. 13. López‐Aguirre C, Hand SJ, Laffan SW, Archer M. Phylogenetic diversity, types of endemism and the evolutionary history of New World bats. Ecography. 2018;41(12):1955–66.
  14. 14. Kunz TH, Braun de Torrez E, Bauer D, Lobova T, Fleming TH. Ecosystem services provided by bats. Ann N Y Acad Sci. 2011;1223:1–38. pmid:21449963
  15. 15. Deshpande K, Vanak AT, Devy MS, Krishnaswamy J. Forbidden fruits? Ecosystem services from seed dispersal by fruit bats in the context of latent zoonotic risk. Oikos. 2022;2022(2).
  16. 16. Tremlett CJ, Peh KS-H, Zamora-Gutierrez V, Schaafsma M. Value and benefit distribution of pollination services provided by bats in the production of cactus fruits in central Mexico. Ecosyst Serv. 2021;47:101197.
  17. 17. Devnath P, Karah N, Graham JP, Rose ES, Asaduzzaman M. Evidence of Antimicrobial Resistance in Bats and Its Planetary Health Impact for Surveillance of Zoonotic Spillover Events: A Scoping Review. Int J Environ Res Public Health. 2022;20(1):243. pmid:36612565
  18. 18. McKee CD, Islam A, Luby SP, Salje H, Hudson PJ, Plowright RK, et al. The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats. Viruses. 2021;13(2):169. pmid:33498685
  19. 19. Streicker DG, Allgeier JE. Foraging choices of vampire bats in diverse landscapes: potential implications for land-use change and disease transmission. J Appl Ecol. 2016;53(4):1280–8. pmid:27499553
  20. 20. Festa F, Ancillotto L, Santini L, Pacifici M, Rocha R, Toshkova N, et al. Bat responses to climate change: a systematic review. Biol Rev Camb Philos Soc. 2023;98(1):19–33. pmid:36054527
  21. 21. DeAnglis IK, Andrews BR, Lock LR, Dyer KE, Yang A, Volokhov DV, et al. Bat cellular immunity varies by year and dietary habit amidst land conversion. Conserv Physiol. 2024;12(1):coad102. pmid:38293641
  22. 22. Gal O, Eitan O, Rachum A, Weinberg M, Zigdon D, Assa R, et al. Air pollution likely reduces hemoglobin levels in urban fruit bats. iScience. 2025;28(3):111997. pmid:40124482
  23. 23. Nunes H, Rocha FL, Cordeiro-Estrela P. Bats in urban areas of Brazil: roosts, food resources and parasites in disturbed environments. Urban Ecosyst. 2017;20(4):953–69. pmid:32214783
  24. 24. Ingala MR, Becker DJ, Bak Holm J, Kristiansen K, Simmons NB. Habitat fragmentation is associated with dietary shifts and microbiota variability in common vampire bats. Ecol Evol. 2019;9(11):6508–23. pmid:31236240
  25. 25. Alpízar P, Risely A, Tschapka M, Sommer S. Agricultural fast food: Bats feeding in banana monocultures are heavier but have less diverse gut microbiota. Frontiers in Ecology and Evolution. 2021;9:746783.
  26. 26. Fleischer R, Jones C, Ledezma-Campos P, Czirják GÁ, Sommer S, Gillespie TR, et al. Gut microbial shifts in vampire bats linked to immunity due to changed diet in human disturbed landscapes. Sci Total Environ. 2024;907:167815. pmid:37852483
  27. 27. Costantini D, Czirják GÁ, Bustamante P, Bumrungsri S, Voigt CC. Impacts of land use on an insectivorous tropical bat: The importance of mercury, physio-immunology and trophic position. Science of The Total Environment. 2019;671:1077–85.
  28. 28. Becker DJ, Chumchal MM, Bentz AB, Platt SG, Czirják GÁ, Rainwater TR, et al. Predictors and immunological correlates of sublethal mercury exposure in vampire bats. R Soc Open Sci. 2017;4(4):170073. pmid:28484633
  29. 29. Becker DJ, Czirják GÁ, Volokhov DV, Bentz AB, Carrera JE, Camus MS, et al. Livestock abundance predicts vampire bat demography, immune profiles and bacterial infection risk. Philos Trans R Soc Lond B Biol Sci. 2018;373(1745):20170089. pmid:29531144
  30. 30. Voigt CC, Kelm DH. Host preference of the common vampire bat (Desmodus rotundus; Chiroptera) assessed by stable isotopes. J Mammal. 2006;87:1–6.
  31. 31. Eby P, Peel AJ, Hoegh A, Madden W, Giles JR, Hudson PJ, et al. Pathogen spillover driven by rapid changes in bat ecology. Nature. 2023;613(7943):340–4. pmid:36384167
  32. 32. Kessler MK, Becker DJ, Peel AJ, Justice NV, Lunn T, Crowley DE, et al. Changing resource landscapes and spillover of henipaviruses. Ann N Y Acad Sci. 2018;1429(1):78–99. pmid:30138535
  33. 33. Becker DJ, Eby P, Madden W, Peel AJ, Plowright RK. Ecological conditions predict the intensity of Hendra virus excretion over space and time from bat reservoir hosts. Ecol Lett. 2023;26(1):23–36. pmid:36310377
  34. 34. Mollentze N, Streicker DG. Viral zoonotic risk is homogenous among taxonomic orders of mammalian and avian reservoir hosts. Proc Natl Acad Sci U S A. 2020;117(17):9423–30. pmid:32284401
  35. 35. Irving AT, Ahn M, Goh G, Anderson DE, Wang L-F. Lessons from the host defences of bats, a unique viral reservoir. Nature. 2021;589(7842):363–70. pmid:33473223
  36. 36. Roffler AA, Maurer DP, Lunn TJ, Sironen T, Forbes KM, Schmidt AG. Bat humoral immunity and its role in viral pathogenesis, transmission, and zoonosis. Front Immunol. 2024;15:1269760. pmid:39156901
  37. 37. Morales AE, Dong Y, Brown T, Baid K, Kontopoulos D-G, Gonzalez V, et al. Bat genomes illuminate adaptations to viral tolerance and disease resistance. Nature. 2025;638(8050):449–58. pmid:39880942
  38. 38. Sippola EA, Johnson JS, Mammola S, Apoznański G, Brila I, Fernández Latapiat I. Impacts of bat use of anthropogenic structures on bats and humans. Conserv Biol. 2025.
  39. 39. Betke BA, Gottdenker NL, Meyers LA, Becker DJ. Ecological and evolutionary characteristics of anthropogenic roosting ability in bats of the world. iScience. 2024;27(7):110369. pmid:39109175
  40. 40. Caranci AT, Grieco JP, Achee NL, Hoel DF, Bautista K, King R, et al. Distribution of Triatoma dimidiata sensu lato (Reduviidae: Triatominae) and Risk Factors Associated with Household Invasion in Northern Belize, Central America. J Med Entomol. 2022;59(2):764–71. pmid:35064668
  41. 41. Stevens L, Monroy MC, Rodas AG, Dorn PL. Hunting, swimming, and worshiping: human cultural practices illuminate the blood meal sources of cave dwelling Chagas vectors (Triatoma dimidiata) in Guatemala and Belize. PLoS Negl Trop Dis. 2014;8(9):e3047. pmid:25211347
  42. 42. Polonio R, Ramirez-Sierra MJ, Dumonteil E. Dynamics and distribution of house infestation by Triatoma dimidiata in central and southern Belize. Vector Borne Zoonotic Dis. 2009;9(1):19–24. pmid:18620512
  43. 43. Moreira F da S, Rodrigues GD, Morales DF, Donalisio MR, Kremer FS, Krüger RF. Effects of climate change on the distribution of Molossus molossus and the potential risk of Orthohantavirus transmission in the Neotropical region. Acta Trop. 2025;261:107497. pmid:39667695
  44. 44. Gunter SM, Nelson A, Kneubehl AR, Justi SA, Manzanero R, Zielinski-Gutierrez E, et al. Novel species of Triatoma (Hemiptera: Reduviidae) identified in a case of vectorial transmission of Chagas disease in northern Belize. Sci Rep. 2024;14(1):1412. pmid:38228608
  45. 45. Chen Y, Fan L-C, Chai Y-H, Xu J-F. Advantages and challenges of metagenomic sequencing for the diagnosis of pulmonary infectious diseases. Clin Respir J. 2022;16(10):646–56. pmid:36068680
  46. 46. Bergner LM, Orton RJ, da Silva Filipe A, Shaw AE, Becker DJ, Tello C, et al. Using noninvasive metagenomics to characterize viral communities from wildlife. Mol Ecol Resour. 2019;19(1):128–43. pmid:30240114
  47. 47. Chandler JA, Liu RM, Bennett SN. RNA shotgun metagenomic sequencing of northern California (USA) mosquitoes uncovers viruses, bacteria, and fungi. Front Microbiol. 2015;6:185. pmid:25852655
  48. 48. National Institute of Health. https://www.ncbi.nlm.nih.gov 2025.
  49. 49. Simmonds SE, Ly L, Beaulaurier J, Lim R, Morse T, Thakku SG, et al. CZ ID: a cloud-based, no-code platform enabling advanced long read metagenomic analysis. 2024. https://doi.org/10.1101/2024.02.29.579666
  50. 50. Peterson JK, Yoshioka K, Hashimoto K, Caranci A, Gottdenker N, Monroy C, et al. Chagas Disease Epidemiology in Central America: an Update. Curr Trop Med Rep. 2019;6: 92–105.
  51. 51. Murray KO, Saldaña MA, Gunter SM, Manzanero R, Zielinski-Gutierrez E, Herrera C, et al. Diagnosis of Acute Chagas Disease in a Belizean Child with Evidence of a Multiclonal Trypanosoma cruzi Infection. Am J Trop Med Hyg. 2022;107(5):992–5. pmid:36395748
  52. 52. Pinto CM, Ocaña-Mayorga S, Tapia EE, Lobos SE, Zurita AP, Aguirre-Villacís F, et al. Bats, Trypanosomes, and Triatomines in Ecuador: New Insights into the Diversity, Transmission, and Origins of Trypanosoma cruzi and Chagas Disease. PLoS One. 2015;10(10):e0139999. pmid:26465748
  53. 53. Bergner LM, Becker DJ, Tello C, Carrera JE, Streicker DG. Detection of Trypanosoma cruzi in the saliva of diverse neotropical bats. Zoonoses Public Health. 2021;68(3):271–6. pmid:33484236
  54. 54. Villena FE, Gomez-Puerta LA, Jhonston EJ, Del Alcazar OM, Maguiña JL, Albujar C, et al. First Report of Trypanosoma cruzi Infection in Salivary Gland of Bats from the Peruvian Amazon. Am J Trop Med Hyg. 2018;99(3):723–8. pmid:30014825
  55. 55. Nichols MD, Lord WD, Haynie ML, Brennan RE, Jackson VL, Monterroso WS. Trypanosoma cruzi in a Mexican Free-Tailed Bat (Tadarida brasiliensis) in Oklahoma, USA. J Wildl Dis. 2019;55(2):444–8. pmid:30277832
  56. 56. Vicente-Santos A, Lock LR, Allira M, Dyer KE, Dunsmore A, Tu W, et al. Serum proteomics reveals a tolerant immune phenotype across multiple pathogen taxa in wild vampire bats. Front Immunol. 2023;14:1281732. pmid:38193073
  57. 57. Dunsmore A, Dyer KE, Lock LR, Tu W, Fenton MB, Simmons NB. Vampire bats in Belize harbor multiple Trypanosoma cruzi genotypes: implications for parasite transmission at the wildlife–domestic–human interface. Molecular Biology. 2025.
  58. 58. Sikes RS, the Animal Care and Use Committee of the American Society of Mammalogists. Guidelines of the American Society of Mammalogists for the use of wild mammals in research and education. J Mammal. 2016;97:663–88.
  59. 59. Volokhov DV, Lock LR, Dyer KE, DeAnglis IK, Andrews BR, Simonis MC, et al. Expanded diversity of novel hemoplasmas in rare and undersampled Neotropical bats. One Health. 2023;17:100633. pmid:37920218
  60. 60. Ansil BR, Lei GS, Santos AJ, Letko M, Seifert SN, Fenton MB. 229E- and NL63-like coronaviruses in phyllostomid bats, Belize. 2025. https://doi.org/10.1101/2025.04.08.647854
  61. 61. Reid FA. A field guide to the mammals of Central America & Southeast Mexico. New York, NY: Oxford University Press. 2009. https://doi.org/10.1093/oso/9780195343229.001.0001
  62. 62. Consortium RN. B-4 blood testing. 2023. https://doi.org/10.17504/protocols.io.rm7vzbze8vx1/v1
  63. 63. Consortium RN. REDI-NET B-4 BLOOD TESTING v2. 2023. https://doi.org/10.17504/protocols.io.rm7vzbze8vx1/v2
  64. 64. Consortium RN. B2- blood processing v1. 2023. https://doi.org/10.17504/protocols.io.x54v9dqemg3e/v1
  65. 65. Li P-E, Lo C-C, Anderson JJ, Davenport KW, Bishop-Lilly KA, Xu Y, et al. Enabling the democratization of the genomics revolution with a fully integrated web-based bioinformatics platform. Nucleic Acids Res. 2017;45(1):67–80. pmid:27899609
  66. 66. Ergunay K, Dincer E, Justi SA, Bourke BP, Nelson SP, Liao H-M, et al. Impact of nanopore-based metagenome sequencing on tick-borne virus detection. Front Microbiol. 2023;14:1177651. pmid:37323891
  67. 67. VanAcker MC, Ergunay K, Webala PW, Kamau M, Mutura J, Lebunge R, et al. A Novel Nobecovirus in an Epomophorus wahlbergi Bat from Nairobi, Kenya. Viruses. 2025;17(4):557. pmid:40285000
  68. 68. Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5(1):e931. pmid:21264349
  69. 69. Seiringer P, Pritsch M, Flores-Chavez M, Marchisio E, Helfrich K, Mengele C, et al. Comparison of four PCR methods for efficient detection of Trypanosoma cruzi in routine diagnostics. Diagn Microbiol Infect Dis. 2017;88(3):225–32. pmid:28456430
  70. 70. Reyes C, González CR, Alvarado S, Flores L, Martin C, Oyarce A, et al. Chagas disease in northern Chile: Detection of Trypanosoma cruzi in children, dogs and triatomine bugs. Acta Trop. 2022;235:106631. pmid:35948082
  71. 71. Rios L, Campos EE, Menon R, Zago MP, Garg NJ. Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165591. pmid:31678160
  72. 72. Shikanai Yasuda MA. Emerging and reemerging forms of Trypanosoma cruzi transmission. Mem Inst Oswaldo Cruz. 2022;117:e210033. pmid:35584508
  73. 73. Steverding D. The history of Chagas disease. Parasit Vectors. 2014;7:317. pmid:25011546
  74. 74. Añez N, Crisante G, Soriano PJ. Trypanosoma cruzi congenital transmission in wild bats. Acta Trop. 2009;109(1):78–80. pmid:18823929
  75. 75. Yoshida N. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:101–7. pmid:19753464
  76. 76. Hayman DTS. Bats as Viral Reservoirs. Annu Rev Virol. 2016;3(1):77–99. pmid:27578437
  77. 77. Matiz-González JM, Silva-Ramos CR, Herrera-Sepúlveda MT, Patiño LH, Ramírez JD, Mateus J, et al. Molecular detection of trypanosomatids among cave-dwelling bats from Colombia. Int J Parasitol. 2025;55(5):253–61. pmid:39832613
  78. 78. França DA de, Louro M, Zúquete S, Zanini D da S, Moraes GN de, Rocha GDS, et al. Trypanosoma cruzi in Bats (Chiroptera; Mammalia) from the Brazilian Atlantic Forest, São Paulo State. Microorganisms. 2024;12(5):945. pmid:38792775
  79. 79. Soto-Vivas A, Nicolalde A, Gavilanez MM, Benalcázar JC, Acosta-López C, Chiluiza J, et al. Trypanosoma cruzi in wild mammals from an endemic area of Chagas disease on the coast of Ecuador. Int J Parasitol Parasites Wildl. 2025;27:101073. pmid:40330609
  80. 80. Moo-Millan JI, Tu W, de Jesús Montalvo-Balam T, Ibarra-López MP, Hernández-Betancourt S, Jesús May-Concha I, et al. Presence of Trypanosoma cruzi TcI and Trypanosoma dionisii in sylvatic bats from Yucatan, Mexico. Trans R Soc Trop Med Hyg. 2024;118(10):659–65. pmid:38695180
  81. 81. Gu W, Miller S, Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annu Rev Pathol. 2019;14:319–38. pmid:30355154
  82. 82. Batool M, Galloway-Peña J. Clinical metagenomics—challenges and future prospects. Front Microbiol. 2023;14:1186424.
  83. 83. Ergunay K, Bourke BP, Achee N, Jiang L, Grieco J, Linton Y-M. Vector-borne pathogen surveillance in a metagenomic world. PLoS Negl Trop Dis. 2024;18(2):e0011943. pmid:38386620
  84. 84. Zheng Y, Qiu X, Wang T, Zhang J. The Diagnostic Value of Metagenomic Next-Generation Sequencing in Lower Respiratory Tract Infection. Front Cell Infect Microbiol. 2021;11:694756. pmid:34568089
  85. 85. Zhao Y, Zhang W, Zhang X. Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases. Front Cell Infect Microbiol. 2024;14:1458316. pmid:39619659
  86. 86. Han D, Li Z, Li R, Tan P, Zhang R, Li J. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019;45(5–6):668–85. pmid:31691607
  87. 87. Blondet L, Mouanda Sounda A, Fritz M, Filloux D, Yvon M, Blanc S, et al. Sentinels tracking viruses in various ecosystems: Towards a One Health approach. PLoS Pathog. 2025;21(5):e1013141. pmid:40435337
  88. 88. National Institute of Health. Disease Reservoirs: Medical Subject Headings. National Library of Medicine. 2020. https://meshb.nlm.nih.gov/record/ui?ui=D004197